New Grant for Metastatic Ewing Sarcoma Research Awarded to Kelly M. Bailey, MD, PhD

UPMC Children’s Division of Pediatric Hematology/Oncology researcher, Kelly M. Bailey, MD, PhD, received a new research grant from the Charlie Landers Foundation through the Children’s Hospital Foundation of Pittsburgh to further her ongoing studies of the role of galectin-3 in metastatic Ewing sarcoma. 

Dr. Bailey’s research hypothesizes that galectin-3 (Gal3) acts as an immunoinhibitory factor in Ewing sarcoma, and proposes to study the impact of Gal3 on tumor immune cell infiltration. 

Learn more about the new grant on the University of Pittsburgh School of Medicine Department of Pediatrics website.

Read these previous articles on Dr. Bailey’s Ewing Sarcoma research program:

• UPMC Children’s Ewing Sarcoma Researcher Awarded 2022 Alex’s Lemonade Stand Foundation Innovation Grant

   

• New Study Uncovers Patterns of Referrals for Cancer Predisposition Syndromes in Pediatric Patients, Assess Barriers to Referrals for Patients

   

• UPMC Children’s Sarcoma Researcher Awarded New K08 Grant

   

• New Findings in Ewing Sarcoma Cell Biology

Learn More About Dr. Bailey.